Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neurorehabilitation|August 16, 2021
A pilot study verifying the effectiveness of high-frequency repetitive transcranial magnetic stimulation in combination with intensive speech-language-hearing therapy in patients with chronic aphasiaKensuke Ohara, Chiaki Kuriyama, Takuya Hada, et al.
Chemical & Pharmaceutical Bulletin|October 4, 2013
Synthesis and biological evaluation of thiophene-C-glucosides as sodium-dependent glucose cotransporter 2 inhibitorsShigeki Sakamaki, Eiji Kawanishi, Yuichi Koga, et al.
Plos One|January 24, 2015
Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetesYoshinori Watanabe, Keiko Nakayama, Nobuhiko Taniuchi, et al.
Journal of Diabetes Investigation|July 27, 2025
Relationship between maternal body composition changes and heavy for date infants in pregnant women with diabetesEriko Eto, Masakazu Kato, Satoe Kirino, et al.
JMA Journal|February 12, 2026
Relationship between Maternal Body Composition during Pregnancy and Newborn Birth Weight in JapanEriko Eto, Masakazu Kato, Satoe Kirino, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 inhibitor Canagliflozin with SGLT1 and SGLT2Ryuichi Ohgaki, Ling Wei, Kazunori Yamada, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2013
N-Glucosides as human sodium-dependent glucose cotransporter 2 (hSGLT2) inhibitorsYasuo Yamamoto, Eiji Kawanishi, Yuichi Koga, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 5, 2025
Determinants of residual myometrial thickness after cesarean delivery: Comparative analysis of barbed versus conventional sutures-A sub-analysis from the SPIRAL trialJota Maki, Hikaru Ooba, Tomohiro Mitoma, et al.
Journal of Pharmacological Sciences|November 28, 2016
Changes in glucose-induced plasma active glucagon-like peptide-1 levels by co-administration of sodium-glucose cotransporter inhibitors with dipeptidyl peptidase-4 inhibitors in rodentsTakahiro Oguma, Chiaki Kuriyama, Keiko Nakayama, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Indole-N-glucoside, TA-1887 As a Sodium Glucose Cotransporter 2 Inhibitor for Treatment of Type 2 DiabetesSumihiro Nomura, Yasuo Yamamoto, Yosuke Matsumura, et al.
Pageof 2